Acute bacterial meningitis in adults

[1]  A. Elhassan,et al.  Role of Clay Minerals in the improvement of Water Quality in the Kingdom of Saudi Arabia (KSA) , 2019, International Journal of Engineering Research and.

[2]  S. Defres,et al.  The UK joint specialist societies guideline on the diagnosis and management of acute meningitis and meningococcal sepsis in immunocompetent Adults (vol 72, pg 405, 2016) , 2016 .

[3]  N. Beeching,et al.  The UK joint specialist societies guideline on the diagnosis and management of acute meningitis and meningococcal sepsis in immunocompetent adults. , 2016, The Journal of infection.

[4]  A. van der Ende,et al.  Community-acquired bacterial meningitis in adults in the Netherlands, 2006-14: a prospective cohort study. , 2016, The Lancet. Infectious diseases.

[5]  M. Gorla,et al.  Genomic resolution of an aggressive, widespread, diverse and expanding meningococcal serogroup B, C and W lineage , 2015, The Journal of infection.

[6]  M. Brouwer,et al.  Corticosteroids for acute bacterial meningitis. , 2015, Cochrane Database of Systematic Reviews.

[7]  M. Sperandio,et al.  Myeloid-related protein 14 promotes inflammation and injury in meningitis. , 2015, The Journal of infectious diseases.

[8]  S. Leib,et al.  Bacterial meningitis: insights into pathogenesis and evaluation of new treatment options: a perspective from experimental studies. , 2015, Future microbiology.

[9]  N. Dartois,et al.  PCVs in individuals at increased risk of pneumococcal disease: a literature review , 2015, Expert review of vaccines.

[10]  S. Kaplan,et al.  Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Pneumococcal Meningitis in US Children. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  M. Shields,et al.  Diagnostic accuracy of loop-mediated isothermal amplification as a near-patient test for meningococcal disease in children: an observational cohort study. , 2015, The Lancet. Infectious diseases.

[12]  N. Andrews,et al.  Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study. , 2015, The Lancet. Infectious diseases.

[13]  S. Halperin,et al.  Outcomes of invasive meningococcal disease in adults and children in Canada between 2002 and 2011: a prospective cohort study. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14]  M. Bottai,et al.  Adult bacterial meningitis: earlier treatment and improved outcome following guideline revision promoting prompt lumbar puncture. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  D. W. Kim,et al.  Clinical Evaluation of a Loop-Mediated Isothermal Amplification (LAMP) Assay for Rapid Detection of Neisseria meningitidis in Cerebrospinal Fluid , 2015, PloS one.

[16]  D. Briles,et al.  Current status and perspectives on protein-based pneumococcal vaccines , 2015, Critical reviews in microbiology.

[17]  D. Grobbee,et al.  Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults. , 2015, The New England journal of medicine.

[18]  H. Smith,et al.  Trends in the epidemiology of invasive Haemophilus influenzae disease in Queensland, Australia from 2000 to 2013: what is the impact of an increase in invasive non-typable H. influenzae (NTHi)? , 2015, Epidemiology and Infection.

[19]  A. Deghmane,et al.  Serogroup C invasive meningococcal disease among men who have sex with men and in gay-oriented social venues in the Paris region: July 2013 to December 2014. , 2015, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[20]  V. Nizet,et al.  Examining the Use of Ceftaroline in the Treatment of Streptococcus pneumoniae Meningitis with Reference to Human Cathelicidin LL-37 , 2015, Antimicrobial Agents and Chemotherapy.

[21]  Bernadette A. Thomas,et al.  Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 , 2015, The Lancet.

[22]  Pierre Vandepapelière,et al.  Adjuvant system AS02V enhances humoral and cellular immune responses to pneumococcal protein PhtD vaccine in healthy young and older adults: randomised, controlled trials. , 2015, Vaccine.

[23]  S. Faust,et al.  Effect of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: an observer-blind, phase 3 randomised clinical trial , 2014, The Lancet.

[24]  G. Leroux-Roels,et al.  Safety, reactogenicity and immunogenicity of a novel pneumococcal protein-based vaccine in adults: a phase I/II randomized clinical study. , 2014, Vaccine.

[25]  A. van der Ende,et al.  A decade of herd protection after introduction of meningococcal serogroup C conjugate vaccination. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[26]  S. Halperin,et al.  The impact of the meningococcal serogroup C conjugate vaccine in Canada between 2002 and 2012. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[27]  S. Marullo,et al.  Invasive meningococcal disease: a disease of the endothelial cells. , 2014, Trends in molecular medicine.

[28]  Minjae Lee,et al.  Epidemiology of bacterial meningitis in the USA from 1997 to 2010: a population-based observational study. , 2014, The Lancet. Infectious diseases.

[29]  A. van der Ende,et al.  Epidemiology of invasive meningococcal disease in the Netherlands, 1960-2012: an analysis of national surveillance data. , 2014, The Lancet. Infectious diseases.

[30]  Y. Iwadate,et al.  Direct application of MALDI-TOF mass spectrometry to cerebrospinal fluid for rapid pathogen identification in a patient with bacterial meningitis. , 2014, Clinica chimica acta; international journal of clinical chemistry.

[31]  D. Lepur,et al.  Therapeutic hypothermia for adult community-acquired bacterial meningitis—Historical control study , 2014, Clinical Neurology and Neurosurgery.

[32]  K. Mølbak,et al.  Impact of 13-valent pneumococcal conjugate vaccination in invasive pneumococcal disease incidence and mortality. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[33]  P. Horby,et al.  Epidemiology, Clinical Manifestations, and Outcomes of Streptococcus suis Infection in Humans , 2014, Emerging infectious diseases.

[34]  J. Ariza,et al.  Streptococcus suis Infection and Malignancy in Man, Spain , 2014, Emerging infectious diseases.

[35]  H. Schønheyder,et al.  Dexamethasone treatment and prognostic factors in community-acquired bacterial meningitis: A Danish retrospective population-based cohort study , 2014, Scandinavian journal of infectious diseases.

[36]  M. Goldacre,et al.  Hospital admission rates for meningitis and septicaemia caused by Haemophilus influenzae, Neisseria meningitidis, and Streptococcus pneumoniae in children in England over five decades: a population-based observational study. , 2014, The Lancet. Infectious diseases.

[37]  H. Erlendsdóttir,et al.  Bacterial meningitis in adults in Iceland, 1995–2010 , 2014, Scandinavian journal of infectious diseases.

[38]  S. Ladhani,et al.  Trends in bacterial, mycobacterial, and fungal meningitis in England and Wales 2004-11: an observational study. , 2014, The Lancet. Infectious diseases.

[39]  C. Dorobăț,et al.  Influence of antibiotic therapy prior to admission on the efficacy of classical methods for the diagnosis of meningococcal disease. , 2014, Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi.

[40]  P. Morelli,et al.  Successful treatment of post-neurosurgical multidrug-resistant Pseudomonas aeruginosa meningo-encephalitis with combination therapy of colistin, rifampicin and doripenem. , 2014, The Journal of antimicrobial chemotherapy.

[41]  A. Karakaş,et al.  Mortality indicators in pneumococcal meningitis: therapeutic implications. , 2014, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[42]  S. Hugonnet,et al.  Epidemiological changes in meningococcal meningitis in Niger from 2008 to 2011 and the impact of vaccination , 2013, BMC Infectious Diseases.

[43]  F. Tubach,et al.  Induced hypothermia in severe bacterial meningitis: a randomized clinical trial. , 2013, JAMA.

[44]  M. Falda,et al.  Genomic comparative analysis and gene function prediction in infectious diseases: application to the investigation of a meningitis outbreak , 2013, BMC Infectious Diseases.

[45]  D. Medini,et al.  Bactericidal antibody against a representative epidemiological meningococcal serogroup B panel confirms that MATS underestimates 4CMenB vaccine strain coverage. , 2013, Vaccine.

[46]  T. Cherian,et al.  Serotype-Specific Changes in Invasive Pneumococcal Disease after Pneumococcal Conjugate Vaccine Introduction: A Pooled Analysis of Multiple Surveillance Sites , 2013, PLoS medicine.

[47]  M. Demar,et al.  Streptococcus suis Meningitis and Bacteremia in Man, French Guiana , 2013, Emerging infectious diseases.

[48]  W. Hryniewicz,et al.  A Decade of Invasive Meningococcal Disease Surveillance in Poland , 2013, PloS one.

[49]  F. P. De la Hoz,et al.  Changes in Streptococcus pneumoniae serotype distribution in invasive disease and nasopharyngeal carriage after the heptavalent pneumococcal conjugate vaccine introduction in Bogotá, Colombia. , 2013, Vaccine.

[50]  K. Sunakawa,et al.  Rapid decrease of 7-valent conjugate vaccine coverage for invasive pneumococcal diseases in pediatric patients in Japan. , 2013, Microbial drug resistance.

[51]  A. van der Ende,et al.  Listeria monocytogenes sequence type 6 and increased rate of unfavorable outcome in meningitis: epidemiologic cohort study. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[52]  O. Wichmann,et al.  A cluster of invasive meningococcal disease in young men who have sex with men in Berlin, October 2012 to May 2013. , 2013, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[53]  A. Sié,et al.  The Causative Pathogen Determines the Inflammatory Profile in Cerebrospinal Fluid and Outcome in Patients with Bacterial Meningitis , 2013, Mediators of inflammation.

[54]  P. Newton,et al.  The use of dried cerebrospinal fluid filter paper spots as a substrate for PCR diagnosis of the aetiology of bacterial meningitis in the Lao PDR , 2013, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[55]  R. Link-Gelles,et al.  Forecasting invasive pneumococcal disease trends after the introduction of 13-valent pneumococcal conjugate vaccine in the United States, 2010-2020. , 2013, Vaccine.

[56]  J. Quevedo,et al.  Role of Oxidative Stress in the Pathophysiology of Pneumococcal Meningitis , 2013, Oxidative medicine and cellular longevity.

[57]  M. Falcone,et al.  Daptomycin plus trimethoprim/sulfamethoxazole combination therapy in post-neurosurgical meningitis caused by linezolid-resistant Staphylococcus epidermidis. , 2013, Diagnostic microbiology and infectious disease.

[58]  S. Awasthi,et al.  Prospective multi-centre sentinel surveillance for Haemophilus influenzae type b & other bacterial meningitis in Indian children , 2013, The Indian journal of medical research.

[59]  A. Zwinderman,et al.  Common polymorphisms in the complement system and susceptiblity to bacterial meningitis. , 2013, The Journal of infection.

[60]  P. Coll,et al.  The spectrum of acute bacterial meningitis in elderly patients , 2013, BMC Infectious Diseases.

[61]  P. Coll,et al.  The changing pattern of bacterial meningitis in adult patients at a large tertiary university hospital in Barcelona, Spain (1982-2010). , 2013, The Journal of infection.

[62]  Kirk E. Smith,et al.  Streptococcus suis Meningitis in Swine Worker, Minnesota, USA , 2013, Emerging infectious diseases.

[63]  M. Hellmann,et al.  Vancomycin-resistant Enterococcus faecium meningitis in adults: Case series and review of the literature , 2013, Scandinavian journal of infectious diseases.

[64]  Z. Memish,et al.  Antibiotic resistance and serotype distribution of invasive pneumococcal diseases before and after introduction of pneumococcal conjugate vaccine in the Kingdom of Saudi Arabia (KSA). , 2012, Vaccine.

[65]  G. Thwaites,et al.  Dilemmas in the diagnosis of acute community-acquired bacterial meningitis , 2012, The Lancet.

[66]  C. Halpern,et al.  Can broad-range 16S ribosomal ribonucleic acid gene polymerase chain reactions improve the diagnosis of bacterial meningitis? A systematic review and meta-analysis. , 2012, Annals of emergency medicine.

[67]  Ryan T Novak,et al.  Serogroup A meningococcal conjugate vaccination in Burkina Faso: analysis of national surveillance data. , 2012, The Lancet. Infectious diseases.

[68]  D. W. Kim,et al.  The Enhanced Pneumococcal LAMP Assay: A Clinical Tool for the Diagnosis of Meningitis Due to Streptococcus pneumoniae , 2012, PloS one.

[69]  M. Jit,et al.  Mathematical Modelling Long-Term Effects of Replacing Prevnar7 with Prevnar13 on Invasive Pneumococcal Diseases in England and Wales , 2012, PloS one.

[70]  Keith A. Jolley,et al.  Resolution of a Meningococcal Disease Outbreak from Whole-Genome Sequence Data with Rapid Web-Based Analysis Methods , 2012, Journal of Clinical Microbiology.

[71]  S. Ladhani,et al.  Invasive meningococcal disease in England and Wales: implications for the introduction of new vaccines. , 2012, Vaccine.

[72]  N. Beeching,et al.  Management of suspected viral encephalitis in adults--Association of British Neurologists and British Infection Association National Guidelines. , 2012, The Journal of infection.

[73]  M. Valenzuela,et al.  Immunogenicity and tolerability of a multicomponent meningococcal serogroup B (4CMenB) vaccine in healthy adolescents in Chile: a phase 2b/3 randomised, observer-blind, placebo-controlled study , 2012, The Lancet.

[74]  Ly-Mee Yu,et al.  Immunogenicity and tolerability of recombinant serogroup B meningococcal vaccine administered with or without routine infant vaccinations according to different immunization schedules: a randomized controlled trial. , 2012, JAMA.

[75]  K. Ko,et al.  Changing Trends in Antimicrobial Resistance and Serotypes of Streptococcus pneumoniae Isolates in Asian Countries: an Asian Network for Surveillance of Resistant Pathogens (ANSORP) Study , 2012, Antimicrobial Agents and Chemotherapy.

[76]  O. Yang,et al.  Combination therapy with daptomycin, linezolid, and rifampin as treatment option for MRSA meningitis and bacteremia. , 2011, Diagnostic microbiology and infectious disease.

[77]  T. Yurtseven,et al.  Linezolid in the treatment of methicillin-resistant staphylococcal post-neurosurgical meningitis: A series of 17 cases , 2011, Scandinavian journal of infectious diseases.

[78]  K. Hanson,et al.  Increasing Incidence of Invasive Haemophilus influenzae Disease in Adults, Utah, USA , 2011, Emerging infectious diseases.

[79]  K. Trivedi,et al.  Mechanisms of meningococcal colonisation. , 2011, Trends in microbiology.

[80]  D. W. Kim,et al.  Loop-Mediated Isothermal Amplification Assay for Detection of Haemophilus influenzae Type b in Cerebrospinal Fluid , 2011, Journal of Clinical Microbiology.

[81]  S. Isenmann,et al.  16S rDNA-PCR and Sequencing Improves Diagnosis of Bacterial Infection of the Central Nervous System , 2011 .

[82]  Z. Bhutta,et al.  5 versus 10 days of treatment with ceftriaxone for bacterial meningitis in children: a double-blind randomised equivalence study , 2011, The Lancet.

[83]  A. Vyse,et al.  Meningococcal disease in Asia: an under-recognized public health burden , 2011, Epidemiology and Infection.

[84]  Y. Lau,et al.  Serotypes and antimicrobial susceptibilities of invasive Streptococcus pneumoniae before and after introduction of 7-valent pneumococcal conjugate vaccine, Hong Kong, 1995-2009. , 2011, Vaccine.

[85]  S. Fukuhara,et al.  Diagnostic accuracy of cerebrospinal fluid lactate for differentiating bacterial meningitis from aseptic meningitis: a meta-analysis. , 2011, The Journal of infection.

[86]  M. Molyneux,et al.  Glycerol adjuvant therapy in adults with bacterial meningitis in a high HIV seroprevalence setting in Malawi: a double-blind, randomised controlled trial. , 2011, The Lancet. Infectious diseases.

[87]  R. Kashyap,et al.  Loop-Mediated Isothermal Amplification for Rapid and Reliable Diagnosis of Tuberculous Meningitis , 2011, Journal of Clinical Microbiology.

[88]  B. Baršić,et al.  Induced hypothermia in adult community-acquired bacterial meningitis--more than just a possibility? , 2011, The Journal of infection.

[89]  J. Blomberg,et al.  Multiplex quantitative PCR for detection of lower respiratory tract infection and meningitis caused by Streptococcus pneumoniae, Haemophilus influenzae and Neisseria meningitidis , 2010, BMC Microbiology.

[90]  A. Pollard,et al.  Multicenter, open-label, randomized phase II controlled trial of an investigational recombinant Meningococcal serogroup B vaccine with and without outer membrane vesicles, administered in infancy. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[91]  F. Sörgel,et al.  Penetration of Drugs through the Blood-Cerebrospinal Fluid/Blood-Brain Barrier for Treatment of Central Nervous System Infections , 2010, Clinical Microbiology Reviews.

[92]  N. Beeching,et al.  Effect of delayed lumbar punctures on the diagnosis of acute bacterial meningitis in adults , 2010, Emergency Medicine Journal.

[93]  R. Read,et al.  Host genetics and outcome in meningococcal disease: a systematic review and meta-analysis. , 2010, The Lancet. Infectious diseases.

[94]  S. Ladhani,et al.  Invasive Haemophilus influenzae Disease, Europe, 1996–2006 , 2010, Emerging infectious diseases.

[95]  B. Gessner,et al.  African meningitis belt pneumococcal disease epidemiology indicates a need for an effective serotype 1 containing vaccine, including for older children and adults , 2010, BMC infectious diseases.

[96]  D. Fisman,et al.  Epidemiology of Invasive Meningococcal Disease with Decreased Susceptibility to Penicillin in Ontario, Canada, 2000 to 2006 , 2010, Antimicrobial Agents and Chemotherapy.

[97]  W. Schaffner,et al.  Changes in Neisseria meningitidis disease epidemiology in the United States, 1998-2007: implications for prevention of meningococcal disease. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[98]  J. McLauchlin,et al.  Disease Presentation in Relation to Infection Foci for Non-Pregnancy-Associated Human Listeriosis in England and Wales, 2001 to 2007 , 2009, Journal of Clinical Microbiology.

[99]  M. Falagas,et al.  Short versus long duration of antibiotic therapy for bacterial meningitis: a meta-analysis of randomised controlled trials in children , 2009, Archives of Disease in Childhood.

[100]  Lee H Harrison,et al.  Global epidemiology of meningococcal disease. , 2009, Vaccine.

[101]  J. Sejvar,et al.  The management of encephalitis: clinical practice guidelines by the Infectious Diseases Society of America. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[102]  A. Chaudhuri,et al.  EFNS guideline on the management of community‐acquired bacterial meningitis: report of an EFNS Task Force on acute bacterial meningitis in older children and adults , 2008, European journal of neurology.

[103]  C. Whitty,et al.  Corticosteroids for bacterial meningitis in adults in sub-Saharan Africa. , 2007, The New England journal of medicine.

[104]  N. M. Duong,et al.  Dexamethasone in Vietnamese adolescents and adults with bacterial meningitis. , 2007, The New England journal of medicine.

[105]  Tom Solomon,et al.  Viral encephalitis: a clinician’s guide , 2007, Practical Neurology.

[106]  J. Timsit,et al.  Detrimental role of delayed antibiotic administration and penicillin-nonsusceptible strains in adult intensive care unit patients with pneumococcal meningitis: The PNEUMOREA prospective multicenter study* , 2006, Critical care medicine.

[107]  Robert B Sim,et al.  Functional Significance of Factor H Binding to Neisseria meningitidis1 , 2006, The Journal of Immunology.

[108]  J. Beneš,et al.  Dynamics of PCR-based diagnosis in patients with invasive meningococcal disease. , 2006, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[109]  P. Gerner-Smidt,et al.  Invasive listeriosis in Denmark 1994-2003: a review of 299 cases with special emphasis on risk factors for mortality. , 2005, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[110]  L. Pinoges,et al.  Ceftriaxone as effective as long-acting chloramphenicol in short-course treatment of meningococcal meningitis during epidemics: a randomised non-inferiority study , 2005, The Lancet.

[111]  U. Reischl,et al.  Rapid Diagnosis of Bacterial Meningitis by Real-Time PCR and Fluorescence In Situ Hybridization , 2005, Journal of Clinical Microbiology.

[112]  A. Blom,et al.  Binding of the Complement Inhibitor C4bp to Serogroup B Neisseria meningitidis 1 , 2005, The Journal of Immunology.

[113]  B. Toye,et al.  Delays in the administration of antibiotics are associated with mortality from adult acute bacterial meningitis. , 2005, QJM : monthly journal of the Association of Physicians.

[114]  K. Mulholland,et al.  MeNZB: a safe and highly immunogenic tailor-made vaccine against the New Zealand Neisseria meningitidis serogroup B disease epidemic strain. , 2005, Vaccine.

[115]  S. Kaplan,et al.  Practice guidelines for the management of bacterial meningitis. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[116]  J. Reitsma,et al.  Clinical features and prognostic factors in adults with bacterial meningitis. , 2004, The New England journal of medicine.

[117]  B. Nunes,et al.  Invasive culture-confirmed Neisseria meningitidis in Portugal: evaluation of serogroups in relation to different variables and antimicrobial susceptibility (2000-2001). , 2004, Journal of medical microbiology.

[118]  J. Carapetis,et al.  Prospective Study of a Real-Time PCR That Is Highly Sensitive, Specific, and Clinically Useful for Diagnosis of Meningococcal Disease in Children , 2004, Journal of Clinical Microbiology.

[119]  M. Taha,et al.  Neisseria meningitidis strains isolated from invasive infections in France (1999-2002): phenotypes and antibiotic susceptibility patterns. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[120]  Mark Thomas,et al.  Three days of intravenous benzyl penicillin treatment of meningococcal disease in adults. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[121]  M. Louie,et al.  Evaluation of a Rapid PCR Assay for Diagnosis of Meningococcal Meningitis , 2003, Journal of Clinical Microbiology.

[122]  A. Joffe.  Dexamethasone in adults with bacterial meningitis. , 2003, The New England journal of medicine.

[123]  D. Beek,et al.  Dexamethasone in adults with bacterial meningitis , 2002 .

[124]  M. Ramsay,et al.  Fatal outcome from meningococcal disease--an association with meningococcal phenotype but not with reduced susceptibility to benzylpenicillin. , 2002, Journal of medical microbiology.

[125]  N. Ganguly,et al.  Evaluation of polymerase chain reaction (PCR) for diagnosing Haemophilus influenzae b meningitis , 2002, Annals of tropical paediatrics.

[126]  D. Brigham,et al.  Streptococcus pneumoniae Causes Experimental Meningitis following Intranasal and Otitis Media Infections via a Nonhematogenous Route , 2001, Infection and Immunity.

[127]  R. Nathaniel,et al.  Rapid diagnosis of acute pyogenic meningitis by a combined PCR dot-blot assay. , 2000, Molecular and cellular probes.

[128]  P. Peduzzi,et al.  Community-Acquired Bacterial Meningitis: Risk Stratification for Adverse Clinical Outcome and Effect of Antibiotic Timing , 1998, Annals of Internal Medicine.

[129]  E. Tuomanen,et al.  Streptococcus pneumoniae anchor to activated human cells by the receptor for platelet-activating factor , 1995, Nature.

[130]  J. Beary,et al.  Surrogate Markers in AIDS , 1992, Annals of Internal Medicine.

[131]  M. H. Terry,et al.  Vaccine against group B Neisseria meningitidis: protection trial and mass vaccination results in Cuba. , 1991, NIPH annals.

[132]  A. Halstensen,et al.  Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway , 1991, The Lancet.

[133]  Bartow,et al.  of Active Bacterial Core Surveillance. , 2015 .

[134]  D. Caugant,et al.  Effect of a serogroup A meningococcal conjugate vaccine ( PsA – TT ) on serogroup A meningococcal meningitis and carriage in Chad : a community trial , 2013 .

[135]  J. Stockman.  Bacterial Meningitis in the United States, 1998–2007 , 2013 .

[136]  K. Stiasny,et al.  Streptococcus suis Meningitis and Bacteremia in Man, French Guiana , 2013 .

[137]  N. Obel,et al.  Long-term mortality in patients diagnosed with Listeria monocytogenes meningitis: a Danish nationwide cohort study. , 2012, The Journal of infection.

[138]  D. Beek.  Adjunctive dexamethasone in bacterial meningitis: a meta-analysis of individual patient data , 2011 .

[139]  C. Khor,et al.  Genome-wide association study identifies variants in the CFH region associated with host susceptibility to meningococcal disease , 2010, Nature Genetics.

[140]  M. Fernández-Ruiz,et al.  Community-acquired methicillin-resistant Staphylococcus aureus meningitis complicated by cerebral infarction. Role of antibiotic combination of linezolid plus levofloxacin. , 2010, Internal medicine.

[141]  D. Beek.  Changes in Neisseria meningitidis Disease Epidemiology in the United States, 1998–2007: Implications for Prevention of Meningococcal Disease , 2010 .

[142]  J. Stockman.  Dexamethasone in Vietnamese Adolescents and Adults with Bacterial Meningitis , 2009 .

[143]  M. Djukic,et al.  Moxifloxacin in experimental Streptococcus pneumoniae cerebritis and meningitis , 2005, Neurocritical care.

[144]  W. Binder,et al.  Dexamethasone in adults with bacterial meningitis. , 2003, The New England journal of medicine.

[145]  D. Stephens,et al.  Pathogenic events during infection of the human nasopharynx with Neisseria meningitidis and Haemophilus influenzae. , 1991, Reviews of infectious diseases.